| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8458090 | Pathology - Research and Practice | 2018 | 7 Pages |
Abstract
A dual marker system using Smad4 and Fascin may be a reliable indicator for predicting clinical outcomes in patients with diffuse-type or EBV-associated gastric cancer.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Byoung Kwan Son, Dong-Hoon Kim, Kyueng-Whan Min, Eun-Kyung Kim, Mi Jung Kwon,